You are the Medical Communications Lead at a pharmaceutical company preparing to launch a new treatment in the United States and other major markets. Recent U.S. policy developments involving Most Favored Nation (MFN) prescription drug pricing, which aims to align...
Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
You are a writer at a medical communications agency supporting development of the first draft of a manuscript reporting primary results from a phase 3 clinical trial. At your client’s request, you are using the pharmaceutical company’s internally developed...
Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
Your team at a sponsoring pharmaceutical company recently published a clinical study in a reputable journal. Soon after, a healthcare professional shared a summary generated by an AI-powered medical tool that appears to overstate the study’s efficacy and...
